|
DYNC1LI1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.20619999999894E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.393000E-04 |
| Normal-vs-Stage2 |
6.189200E-04 |
| Normal-vs-Stage3 |
1.032200E-02 |
| Normal-vs-Stage4 |
3.45999999995517E-06 |
| Stage1-vs-Stage2 |
4.196800E-01 |
| Stage1-vs-Stage3 |
8.977000E-01 |
| Stage1-vs-Stage4 |
8.583600E-03 |
| Stage2-vs-Stage3 |
5.412200E-01 |
| Stage2-vs-Stage4 |
2.188000E-01 |
| Stage3-vs-Stage4 |
4.198100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77916999999361E-05 |
| Normal-vs-AfricanAmerican |
1.979370E-03 |
| Normal-vs-Asian |
3.878800E-01 |
| Caucasian-vs-AfricanAmerican |
5.734400E-01 |
| Caucasian-vs-Asian |
6.985000E-01 |
| AfricanAmerican-vs-Asian |
8.570600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.96940000032997E-07 |
| Normal-vs-Female |
2.485800E-01 |
| Male-vs-Female |
2.44729999999693E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.838630E-03 |
| Normal-vs-Extreme_Weight |
1.36660000005229E-06 |
| Normal-vs-Obese |
5.644900E-04 |
| Normal-vs-Extreme_Obese |
1.564000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.376400E-01 |
| Normal_Weight-vs-Obese |
8.236600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.544600E-01 |
| Extreme_Weight-vs-Obese |
2.385400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.073600E-01 |
| Obese-vs-Extreme_Obese |
9.470000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.843800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.822000E-04 |
| Normal-vs-Age(61-80Yrs) |
9.93859999964819E-07 |
| Normal-vs-Age(81-100Yrs) |
8.463900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.456600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.769600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.200000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.405800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.573200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.020400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.767330E-04 |
| Normal-VS-Type2 PRCC |
7.56570000000067E-05 |
| Normal-VS-KIRP CIMP |
7.427400E-01 |
| Normal-VS-Unclassified PRCC |
3.084800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.862630E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.253220E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.266200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.659600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.429400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.067160E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18660000003601E-06 |
| Normal-vs-N1 |
1.019980E-03 |
| Normal-vs-N2 |
1.804260E-04 |
| N0-vs-N1 |
2.006800E-01 |
| N0-vs-N2 |
3.262800E-01 |
| N1-vs-N2 |
4.871700E-02 |
|
|
